SARS-COV-2 Spike Protein Rabbit pAb
ENT-A16071
Description
| REF | ENT-A16071 |
|---|---|
| Category | Antibody Polyclonal |
| Description | SARS-COV-2 Spike Protein Rabbit pAb |
| Source | Rabbit |
| Applications | WB |
| Reactivity | Human virus |
| Reactivity | Human virus |
| Dilution | WB 1:1000-2000 |
| Immunogen | Synthesized peptide derived from SARS-COV-2 Spike Protein |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | |
| Human Gene ID | |
| Human Swiss Prot Nº | P0DTC2 |
| Subcellular Location |
Other Name: YM33056
Background: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It’s been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor.